gut microbiota

The double-edged sword of dietary fiber: tailoring fiber intake for gut health in autoimmune conditions

Heather Armstrong, from University of Manitoba and University of Alberta (Canada), explores the intricate role of dietary fibers in maintaining gut health, focusing on the microbiome’s ability to process these…

Tumor microbiome, immunity, and prognosis: a comprehensive atlas

This article presents “The Cancer Microbiota Database," an interactive and customizable tool to investigate 33 types of cancers.

Specific gut metabolites may help diagnose endometriosis

The findings suggest that 4-hydroxyindole could be a promising biomarker for diagnosing endometriosis.

Core gut microbiota signature may serve as health indicator

The study identified a core microbiota signature that may serve as a health indicator and a therapeutic target.

Understanding the gut microbiota in athletes

Standardizing microbiome analysis improves the quality and reliability of data, helping researchers to explore the gut microbiota’s impact on athletes and its relationship with health and performance.

Microbiota linked to susceptibility to necrotizing enterocolitis in preemies

The results also indicate that the hospital environment influences the gut bacteria of preterm infants, highligting the importance of managing antibiotics and medications to support a healthy gut development.

Microbiome’s implications in recurrent pregnancy loss

A systematic review recently published in the Journal of Reproductive Immunology provides a comprehensive overview of the emerging role of the microbiome in recurrent pregnancy loss (RPL).

QIAGEN and McGill University partner to drive innovation in microbiome research

Three-year collaboration to pioneer new insights in microbial sciences and health applications.

Dietary fiber, bloutia, and mucus function: uncovering potential for Next-Generation Probiotics

The interview with Björn O. Schröder from Umeå University explores groundbreaking research on the gut mucus layer, which shields intestinal tissues from bacterial invasion and inflammation.

EnteroBiotix’s EBX-102 shows promising Phase 1b results for liver cirrhosis treatment

New microbiome based therapy demonstrates safety and potential benefits for liver cirrhosis and mental health.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top